BioInvent International Aktiebolag
556537-7263ActiveClinical-stage company developing novel immuno-oncology antibody therapeutics for cancer.
Översikt
- 100–199
- Anställda
- 20–50milj SEK
- Omsättning
- 1997
- Grundat
Nyckelbeslutsfattare
Cecilia Hofvander
VP Investor Relations
Thomas Hecht
Member of the Board
Anette Mårtensson
Employee deputy, Member of the Board
Emma Meurling
HR Director
+19 fler kontakter i Funnelfeedr
Beskrivning
BioInvent is a clinical-stage biotechnology company focused on discovering and developing innovative antibody therapeutics for cancer treatment. The core of their work lies in leveraging deep expertise in immunology, cancer biology, and antibody biology to generate novel immuno-oncology drug candida...
Taggar
Nyckelord
Teknikstack
Företagsinformation
- Bransch
- Bioteknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE556537726301
Beslutsfattare
23 kontakter i FunnelfeedrCecilia Hofvander
VP Investor Relations
Thomas Hecht
Member of the Board
Anette Mårtensson
Employee deputy, Member of the Board
Emma Meurling
HR Director
Nanna Lüneborg
Member of the Board
Andres McAllister
Chief Medical Officer
Kristoffer Bissessar
Member of the Board
Björn Frendéus
CSO
Leonard Kruimer
Chairman of the Board
Martin Welschof
Chief Executive Officer
Kristoffer Rudenholm Hansson
Senior Vice President, Technical Operations
Natalie Berner
Member of the Board
Vincent Ossipow
Member of the Board
Laura Lassouw-Polman
Member of the Board
Bernd Seizinger
Member of the Board
Sylvie Ryckebusch
Chief Business Officer
Stefan Ericsson
Chief Financial Officer
Ashley Robinson
Senior Vice President Strategy & Finance
Ingunn Munch Lindvig
Senior Vice President Regulatory Affairs
Övriga kontakter
Marina Mangold
Data Protection Officer
Mona Welschof
Clinical Operations
Tomas Wall
Employee Representative
Elin Birgersson
Employee Representative
Liknande företag
20 liknande företag i FunnelfeedrAlligator Bioscience AB
10–19 anställdaClinical-stage biotech developing tumor-directed immuno-oncology antibody drugs.
CAEDO ONCOLOGY AS
Developing novel monoclonal antibodies for targeted cancer immunotherapy treatment.
Active Biotech AB (publ)
1–4 anställdaDeveloping novel treatments for cancer and inflammatory eye diseases.
Affibody AB
50–99 anställdaDeveloping next-generation radiopharmaceuticals using proprietary Affibody technology.
Respiratorius AB (publ)
Developing novel drugs to treat aggressive lymphoma cancers.
Utforska mer
Frågor om BioInvent International Aktiebolag
Vill du se Funnelfeedr i praktiken?
Boka en gratis demo och upptäck hur Funnelfeedr hjälper dig att hitta och konvertera dina idealkunder.
Boka en demo